1 / 6

Middle East Dermal Fillers Market Analysis Report 2023

The Middle East dermal fillers market is projected to cross $67.7 million by 2023. The growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income.

psmarket
Download Presentation

Middle East Dermal Fillers Market Analysis Report 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Middle East Dermal Fillers Market to Reach $67.7 Million by 2023

  2. Middle East dermal fillers market is forecasted to generate a revenue of $67.7 million by 2023. The growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income. Explore report at: https://www.psmarketresearch.com/market-analysis/middle-east-dermal-fillers-market “

  3. On the basis of the type of dermal fillers, the market is categorized into hyaluronic acid-based, hydroxylapatite-based, synthetic polymer-based, and collagen-based fillers. Till now, hyaluronic acid-based fillers have been accounting for the largest share in the dermal fillers market of the Middle East. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to the ability of these tissue fillers to attract water molecules, which aids in hydration and increasing skin volume. On the basis of application, the dermal fillers market in the Middle East has been segmented into facial line correction, face lift, lip treatment, and others. Facial line correction has been holding the largest share in the dermal fillers market, with an estimated revenue contribution of 45.6% in 2017. It is also expected to be the fastest growing category during the forecast period, due to increasing number of patients opting for this treatment. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=middle-east-dermal-fillers-market

  4. Historically, in terms of size, Saudi Arabia has been leading the dermal fillers industry in the Middle East. This can be attributed to growing aging population, increasing demand for cosmetic procedures, and availability of skilled practitioners for dermal filler procedures in the country. According to UNDESA, the proportion of people in Saudi Arabia aged 60 years and above is predicted to be 25% of the total population of 40 million by the end of 2050, leading to the growth of the market in Saudi Arabia, and thereby, maintaining its leading position in the Middle East. Request for report sample at: https://www.psmarketresearch.com/market-analysis/middle-east-dermal-fillers-market/report-sample

  5. In the Middle East, key players in the dermal fillers industry are launching tissue fillers based on hyaluronic acid to gain a larger market share. For instance, in March 2018, Galderma S.A. in collaboration with AMCo Group and Medica Group, launched two Restylane hyaluronic acid fillers in Saudi Arabia, namely RestylaneRefyne and RestylaneDefyne. Some of the other major players operating in the dermal fillers market include Allergan plc, MerzPharma GmbH & Co. KGaA, Sinclair Pharmaplc, and Teoxane Laboratories.

  6. THANK YOU! For queries, kindly write to: enquiry@psmarketresearch.com GET IN TOUCH www.psmarketresearch.com B-13, Sector-2, Noida, U.P.-201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 US/Canada Toll-Free: 1-888-778-7886

More Related